Skip to main content
. 2021 Aug 9;19:339. doi: 10.1186/s12967-021-03004-z

Fig. 3.

Fig. 3

BCLAF1 Ser290 phosphorylation is correlated with gastric cancer development. a Immunohistochemistry on gastric tumor tissues and adjacent non-tumor tissues using pBCLAF1 (Ser290) antibody (up-panel 40 × and lower panel 100 × , respectively). b Statistical data to show the IHC score of pBCLAF1 (Ser290) staining in the gastric tumor tissues (n = 95) and adjacent non-tumor tissues (n = 85). ***p < 0.001, Student's t-test. c Kaplan–Meier survival curve showed that high pBCLAF1 (Ser290) level correlated with poor overall survival of GC patients. p = 0.017, log-rank test